Antiviral Drugs Market is expected to grow at a steady pace by 2027 | CAGR: 3.4% | UnivDatos Market Insights

News provided by

UnivDatos Market Insights Pvt. Ltd.

30 May, 2022, 20:30 IST

NOIDA, India, May 30, 2022 /PRNewswire/ -- A comprehensive overview of the Antiviral Drugs Market is recently added by UnivDatos Market Insights to its humongous database. The report has been aggregated by collecting informative data from various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the Antiviral Drugs Market. The report offers a detailed analysis of the latest industry developments and trending factors that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the Antiviral Drugs Market at the regional levels. The Antiviral Drugs Market is expected to grow at a CAGR of ~ 3.4% between 2021-2027.

Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=19627

Market Overview

The global Antiviral Drugs market is expected to witness robust growth mainly due to the growing cases of viral infections, and initiatives toward proper use and distribution of antiviral drugs & management coupled with rising in Pediatric, Adult, and Geriatric populations. Furthermore, infectious mononucleosis, mutation of viruses, prolonged use of antiviral drugs for the fever, infection, and certain medications & supplements are some of the major causes of increasing issues of viral infections. Continuous technological advancements coupled with the development of new drugs and therapies for the treatment of Antiviral by major players like AbbVie Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., are other major factors driving the Antiviral Drugs market.

COVID-19 Impact

The ongoing COVID-19 pandemic across the world has had a tremendous impact on different spectra of society, the market for Antiviral Drugs no less. Returning to some likeness of normalcy depends on continued safety measures, effective diagnostic testing, and widespread vaccination. For instance, in June 2021, the U.S. government announced an investment of more than USD 3 billion to fasten the discovery, development, and manufacturing of antiviral medicines for COVID-19 treatment. Major players in the market have been at the center of the fight since the health crisis began, enabling research on the virus, ensuring the supply of critical kits and consumables, delivering the gold standard in testing, and supporting the development, production, and distribution of vaccines and treatments.

Ask for Price & Discounts @ https://univdatos.com/get-a-free-sample-form-php/?product_id=19627

Antiviral Drugs Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

By Drug Class, the market is primarily bifurcated into:

  • Reverse Transcriptase Inhibitors
  • DNA polymerase inhibitors
  • Protease Inhibitors
  • Others

Based on Drug class, the Antiviral Drugs Market is segmented into Reverse Transcriptase Inhibitors, DNA polymerase inhibitors, Protease Inhibitors, and Others. In 2020, the Reverse Transcriptase Inhibitors category dominated the market and is expected to maintain its dominance throughout the forecast period.

By Application, the market is primarily studied into:

  • HIV
  • Hepatitis
  • Herpes
  • Influenza
  • Others

Based on application, the market is bifurcated into topical, oral, and injectable. Among these, the injectable category accounted for the major share of the global Antiviral Drugs.

By Distribution Channel, the market is primarily studied into:

  • Hospitals and Clinics
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

Based on distribution channel, the market is bifurcated into hospitals and clinics, drug stores and retail pharmacies, and online pharmacies. During the forecast period, the hospital pharmacies category is expected to witness robust growth during the forecast period.

Antiviral Drugs Market Region Segmentation Includes:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Based on the estimation, Geographically, North America leads the market adding up to 56% business share in 2021. This can be mainly ascribed to the high R&D expenditure by pharmaceutical and biopharmaceutical companies, and surging investments by governments, coupled with an increasing focus on quality and manufacturing efficiency improvement in the region.

Ask for Report Customization @ https://univdatos.com/report/antiviral-drugs-market/

The major players targeting the market include:

  • Gilead Sciences
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc.
  • AbbVie, Merck & Co. Inc.
  • Johnson & Johnson Services Inc.
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Aurobindo Pharma
  • Dr Reddy's Laboratories Ltd.
  •  Glenmark Pharmaceuticals Ltd.

 Competitive Landscape

The degree of competition among prominent companies has been elaborated by analyzing several leading key players operating in the global context. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the Antiviral Drugs Market. The major players have been analyzed using different research methodologies for getting insight views on market competition.

Key questions resolved through this analytical market research report include:

  • What are the latest trends, new patterns, and advancements in the Antiviral Drugs Market?
  • Which factors are influencing the Antiviral Drugs Market over the forecast period?
  • What are the challenges, threats, and risks in the Antiviral Drugs Market?
  • Which factors are propelling and restraining the Antiviral Drugs Market?
  • What are the demanding regions of the Antiviral Drugs globally?
  • What will be the market size in the upcoming years?
  • What are the crucial market acquisition strategies and policies applied by the companies?

We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature. Please let us know If you have any custom needs.

For more informative information, please visit us @ https://univdatos.com/report/antiviral-drugs-market/

Browse Other Related Research Reports from UnivDatos Market Insights

About UnivDatos Market Insights

UnivDatos Market Insights (UMI) is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. Our research studies are spread across topics across the world, we cover markets in over 100 countries using smart research techniques and agile methodologies. We offer in-depth studies, detailed analysis, and customized reports that help shape winning business strategies for our clients.

Contact
UnivDatos Market Insights
Ankita Gupta
Director Operations
Ph: +91-7838604911
Email: [email protected]
Website: https://univdatos.com/

Logo: https://mma.prnewswire.com/media/1225049/UnivDatos_Logo.jpg